NATURASONE Trademark

Trademark Overview


On Wednesday, August 16, 2000, a trademark application was filed for NATURASONE with the United States Patent and Trademark Office. The USPTO has given the NATURASONE trademark a serial number of 76113578. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, July 11, 2009. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The NATURASONE trademark is filed in the Pharmaceutical Products category with the following description:

medical diagnostic and pharmaceutical preparations including steroid hormone compound(s), dehydroepiandrosterone derivatives and salts, for testing and treatment of human and non-human animal respiratory, central nervous system, immune, endocrine, neoplastic and cardiovascular ailments, including bronchoconstriction, anxiety, pre menstrual syndrome, menopause symptoms, anxiety, lack of sleep, aggressive or socially inappropriate behaviour, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, respiratory airway and pulmonary diseases and conditions, such as asthma, pulmonary vascoconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome infantile ARDS, pain c...
naturasone

General Information


Serial Number76113578
Word MarkNATURASONE
Filing DateWednesday, August 16, 2000
Status710 - CANCELLED - SECTION 8
Status DateSaturday, July 11, 2009
Registration Number2655563
Registration DateTuesday, December 3, 2002
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 10, 2002

Trademark Statements


Goods and Servicesmedical diagnostic and pharmaceutical preparations including steroid hormone compound(s), dehydroepiandrosterone derivatives and salts, for testing and treatment of human and non-human animal respiratory, central nervous system, immune, endocrine, neoplastic and cardiovascular ailments, including bronchoconstriction, anxiety, pre menstrual syndrome, menopause symptoms, anxiety, lack of sleep, aggressive or socially inappropriate behaviour, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, respiratory airway and pulmonary diseases and conditions, such as asthma, pulmonary vascoconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome infantile ARDS, pain cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vascoconstriction, emphysema, chronic obstructive pulmonary disease (COPD) as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate
Pseudo MarkNATURALS 1

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, July 11, 2009
Primary Code005
First Use Anywhere DateWednesday, December 31, 1997
First Use In Commerce DateThursday, December 31, 1998

Trademark Owner History


Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Saturday, July 11, 2009CANCELLED SEC. 8 (6-YR)
Friday, January 18, 2008CASE FILE IN TICRS
Tuesday, December 3, 2002REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2002PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2002NOTICE OF PUBLICATION
Friday, June 7, 2002PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, January 28, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 27, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 22, 2001NON-FINAL ACTION MAILED
Wednesday, March 14, 2001ASSIGNED TO EXAMINER
Friday, February 16, 2001ASSIGNED TO EXAMINER